Children's Hospital Medical Center, Cincinnati

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Children's Hospital Medical Center, Cincinnati sits in the top decile of US sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count).

571 total trials 106 currently recruiting 372 completed early-phase tilt top decile by trial count

Children's Hospital Medical Center, Cincinnati: 571 sponsored US clinical trials, 106 recruiting.

Children's Hospital Medical Center, Cincinnati sponsors 571 registered US clinical trials on ClinicalTrials.gov, 106 of them currently recruiting, and 372 completed. 38 of these trials are in Phase 3-4 (later-stage) and 140 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 13 trials.

Top-decile sponsor footprint

Children's Hospital Medical Center, Cincinnati ranks in the top decile of sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

372 of 412 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

571 total, page 7 of 12

COMPLETED Phase 2

An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

NCT03029091

TERMINATED Phase 2

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

NCT03095248

COMPLETED NA

Remote Access: Cortical Visual Impairment

NCT03957980

COMPLETED Phase 4

TRPV2 Agonists in the Fontan Circulation

NCT03965351

COMPLETED

Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)

NCT02990598

COMPLETED NA

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

NCT03093805

TERMINATED Phase 2

Acute Effects of Inhaled Treprostinil in Fontan Patients

NCT02769624

COMPLETED NA

Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates

NCT03039257

TERMINATED NA

Methods to Detect Liver Fibrosis

NCT03027700

COMPLETED NA

Improving ADHD Teen Driving

NCT02848092

COMPLETED NA

Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure

NCT03017924

COMPLETED

Ultrasound Quantification of Liver Fat

NCT04523584

COMPLETED NA

Sex and Age Ultrasound Response to Differential Jugular Vein Pressure

NCT03017937

COMPLETED Phase 4

Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients

NCT02946203

COMPLETED NA

Trial of Enhanced Pre-Consent Discussion

NCT02869880

COMPLETED NA

Brain Dynamics in Response to Jugular Vein Compression

NCT03236389

COMPLETED

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

NCT02652533

COMPLETED

ISE to Support Constipation Management

NCT02977858

TERMINATED NA

High Dose Vitamin D Replacement in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT02876822

COMPLETED NA

MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics

NCT02869893

TERMINATED NA

Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction

NCT03076931

COMPLETED NA

Use of a 3D Printer to Make Custom Sleep Masks for Positive Airway Pressure Treatment

NCT02896751

COMPLETED

Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort

NCT02897271

COMPLETED NA

Effects of Neuromuscular Training on EEG Adaptations in Young Athletes

NCT03913975

COMPLETED NA

Concussion Prevention in Female Soccer Athletes

NCT03014492

COMPLETED Phase 1

Dexmedetomidine and Ketamine in MRI

NCT02652507

COMPLETED

Comparative Effects of Two Anesthetic Techniques on Auditory Brain Response in Children

NCT02830815

COMPLETED NA

Gastric Emptying Ultrasound Research Study

NCT02938065

COMPLETED Phase 2

SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study

NCT02778867

COMPLETED NA

Supplement to Hospital to Home Outcomes

NCT03224130

COMPLETED

Anti-TNF Therapy for Refractory Colitis in Hospitalized Children

NCT02799615

COMPLETED NA

Cognitive and Behavioral Effects of Sleep Restriction in Adolescents With ADHD

NCT02732756

COMPLETED NA

An Intervention to Reduce Second Hand Smoke Exposure Among Pediatric Emergency Patients

NCT02531594

TERMINATED Phase 1

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

NCT02607124

COMPLETED Phase 3

Pain Reduction With Intranasal Medications for Extremity Injuries

NCT02778880

COMPLETED NA

Improving Self-Management in Adolescents With Sickle Cell Disease

NCT02851615

COMPLETED Phase 2

Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids

NCT02610816

COMPLETED

Testing the Reliability and Validity of the CIBA

NCT02882594

COMPLETED Early Phase 1

Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD

NCT02874690

COMPLETED NA

Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants

NCT02858154

COMPLETED Early Phase 1

Neurophysiological and Acute Pharmacological Studies in FXS Patients

NCT02998151

COMPLETED Phase 1

Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children

NCT02836431

COMPLETED NA

Clinical Outcomes Following Patellar Dislocation in Young Athletes

NCT03040232

COMPLETED NA

Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention

NCT03018548

COMPLETED NA

Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools

NCT02735174

COMPLETED Phase 1

Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder

NCT02611921

COMPLETED NA

Illness Management and Parental Adjustment to Cancer Treatment

NCT02505165

COMPLETED Phase 4

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

NCT02542462

COMPLETED

PKU Skin Stripping

NCT04368624

COMPLETED

Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)

NCT02862418

← Previous Page 7 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 54
Phase 3 15
Phase 4 23

What is open in the Children's Hospital Medical Center, Cincinnati pipeline

106 recruiting of 571 indexed (19% open); 372 completed (65%).

Phase mix: 38 late (III/IV) vs 140 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Children's Hospital Medical Center, Cincinnati: open-pipeline peers nationwide

Peers matched on 571 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 5%10%15%20%25%30% Total trials Recruiting share Children's Hospital Medical Center, CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)City of Hope Medical CenterUniversity of Maryland, BaltimoreAmgenArkansas Children's Hospital Research InstituteUniversity of Missouri-ColumbiaMclean HospitalMontefiore Medical Center
Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 571 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Children's Hospital Medical Center, Cincinnati page

571 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Medical Center, Cincinnati or any single study.

  • 106 of Children's Hospital Medical Center, Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autism Spectrum Disorder is the condition Children's Hospital Medical Center, Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Children's Hospital Medical Center, Cincinnati pipeline card: 571 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.